Glomerulonephritis

Adolescent Medicine Clinics

Volumn 16, Issue 1, 2005, Pages 67-85

  Lau, Keith K ^a,b   Wyatt, Robert J ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACUTE DISEASE; ALLERGIC GLOMERULONEPHRITIS; ALPORT SYNDROME; ANAPHYLACTOID PURPURA; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; RENOVASCULAR HYPERTENSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ADOLESCENT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; NEPHRITIS, HEREDITARY; PURPURA, SCHOENLEIN-HENOCH;

EID: 10944226434     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.09.008     Document Type: Review

References (103)

1. A. Eddy Molecular basis of renal fibrosis Pediatr Nephrol 15 2000 290 301
2. C.H. Crompton, P.B. Ward, and I.K. Hewitt The use of urinary red cell morphology to determine the source of hematuria in children Clin Nephrol 39 1993 44 49
3. A.K. Dinda, S. Saxena, and S. Guleria Diagnosis of glomerular haematuria: role of dysmorphic red cell, G1 cell and bright-field microscopy Scand J Clin Lab Invest 57 1997 203 208
4. W.K. Bolton, and B.C. Sturgill Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis Am J Nephrol 9 1989 368 375
5. W.K. Bolton Rapidly progressive glomerulonephritis Semin Nephrol 16 1996 517 526
6. B.R. Cole, J.T. Brocklebank, and R.A. Kienstra "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis J Pediatr 88 1976 307 314
7. A.A. Kaplan Therapeutic plasma exchange for the treatment of rapidly progressive glomerulonephritis Ther Apher 1 1997 255 259
8. Southwest Pediatric Nephrology Study Group A clinico-pathological study of crescentic glomerulonephritis in 50 children Kidney Int 27 1985 450 458
9. M.N. Miller, R. Baumal, and S. Poucell Incidence and prognostic importance of glomerular crescents in renal diseases of childhood Am J Nephrol 4 1984 244 247
10. A.J. Fish, R.C. Herdman, and A.F. Michael Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. II. Correlative study of light, immunofluorescent and electron microscopic findings Am J Med 48 1970 28 39
11. G. Peter, and A.L. Smith Group A streptococcal infections of the skin and pharynx (first of two parts) N Engl J Med 11 1977 311 317
12. S. Roy III, J.A. Pitcock, and J.N. Etteldorf Prognosis of poststreptococcal glomerulonephritis in childhood: prospective study and review of the literature Adv Pediatr 23 1976 35 69
13. E. Bodaghi, S. Vazirian, and M. Abtahi Glomerular diseases in children. The Iranian experience Pediatr Nephrol 3 1989 213 217
14. S. Roy III, and F.B. Stapleton Changing perspectives in children hospitalized with poststreptococcal acute glomerulonephritis Pediatr Nephrol 4 1990 585 588
15. H.K. Yap, K.S. Chia, and B. Murugasu Acute glomerulonephritis-changing patterns in Singapore children Pediatr Nephrol 4 1990 482 484
16. C.F. Strife, A.J. McAdams, and P.T. McEnery Hypocomplementemic and normocomplementemic acute nephritis in children: a comparison with respect to etiology, clinical manifestations, and glomerular morphology J Pediatr 84 1974 29 38
17. J.S. Cameron, R.M. Vick, and C.S. Ogg Plasma C3 and C4 concentrations in management of glomerulonephritis BMJ 3 1973 668 672
18. R.J. Wyatt, J. Forristal, and C.D. West Complement profiles in acute post-streptococcal glomerulonephritis Pediatr Nephrol 2 1988 219 223
19. N. Hinglais, R. Garcia-Torres, and D. Kleinknecht Long-term prognosis in acute glomerulonephritis. The predictive value of early clinical and pathological features observed in 65 patients Am J Med 56 1974 52 60
20. A. Tejani, and E. Ingulli Poststreptococcal glomerulonephritis: current clinical and pathologic concepts Nephron 55 1990 1 5
21. A.R. Nissenson, L.J. Baraff, and R.J. Fine Poststreptococcal acute glomerulonephritis: fact and controversy Ann Intern Med 91 1979 76 86
22. I. Sagel, G. Treser, and A. Ty Occurrence and nature of glomerular lesions after group A streptococci infections in children Ann Intern Med 79 1973 492 499
23. T. Tornroth The fate of subepithelial deposits in acute poststreptococcal glomerulonephritis Lab Invest 35 1976 461 474
24. H. Villarreal Jr, V.A. Fischetti, and I. van de Rijn The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis J Exp Med 149 1979 459 472
25. S. Roy III, H.P. Wall, and J.N. Etteldorf Second attacks of acute glomerulonephritis J Pediatr 75 1969 758 767
26. L.E. Hebert, W.A. Wilmer, and M.E. Falkenheim Renoprotection: one or many therapies? Kidney Int 59 2001 1211 1223
27. K.K. Lau, L.W. Gaber, and N.M. Delos Santos Pediatric IgA nephropathy: clinical features at presentation and outcome for African-Americans and Caucasians Clin Nephrol 62 3 2004 167 172
28. J. Berger IgA glomerular deposits in renal disease Transplant Proc 1 1969 939 944
29. N. Yoshikawa, H. Ito, and S. Yoshiara Clinical course of IgA nephropathy in children J Pediatr 110 1987 555 560
30. R.J. Wyatt, B.A. Julian, and D.B. Bhathena IgA nephropathy: presentation, clinical course, and prognosis in children and adults Am J Kidney Dis 4 2 1984 192 200
31. R.J. Wyatt, S.B. Kritchevsky, and S.Y. Woodford IgA nephropathy: long-term prognosis for pediatric patients J Pediatr 127 1995 913 919
32. M. Haas Histological subclassification of IgA nephropathy: a clinicopathologic study of 244 cases Am J Kidney Dis 29 1997 829 842
33. R.J. Wyatt, B.A. Julian, and R.W. Baehler Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994 J Am Soc Nephrol 9 1998 853 858
34. R.J. Wyatt The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects Contrib Nephrol 104 1993 82 91
35. B.A. Julian, R.J. Wyatt, and R.G. McMorrow Serum complement proteins in IgA nephropathy Clin Nephrol 20 1993 251 258
36. N.M. Delos Santos, and R.J. Wyatt Pediatric IgA nephropathy: clinical aspects and therapeutic approaches Semin Nephrol 24 3 2004 269 286
37. R.J. Hogg, F.G. Silva, and R.J. Wyatt Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group Pediatr Nephrol 8 1994 15 20
38. R.J. Wyatt, and R.J. Hogg Evidence-based assessment of treatment options for children with IgA nephropathies Pediatr Nephrol 16 2001 157 166
39. J.V. Donadio Jr, E.J. Bergstralh, and K.P. Offord A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group N Engl J Med 331 1994 1194 1199
40. R.J. Hogg for the Scientific Planning Committee of the IgA Nephropathy Study A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy Am J Kidney Dis 26 1995 792 796
41. R.J. Hogg, J. Lee, and N.A. Nardelli Multicenter placebo-controlled trial of alternate-day prednisone (QOD-PRED) or daily omega-3 fatty acids (OM-3 FA) in children and young adults with IgA nephropathy (IgAN). Report from the Southwest Pediatric Nephrology Study Group J Am Soc Nephrol 14 2003 751A
42. E.M. Eugui, A. Mirkovich, and A.C. Allison In vitro immunosuppressive effects of mycophenolic acid and an ester pro drug, RS-61443 Transplant Proc 23 Suppl 2 1991 10 14
43. A.K. Bayazit, A. Noyan, and N. Cengiz Mycophenolate mofetil in children with multidrug-resistant nephrotic syndrome Clin Nephrol 61 2004 25 29
44. R. Nowack, R. Birck, and F.J. van der Woude Mycophenolate mofetil for systemic vasculitis and IgA nephropathy Lancet 349 1997 1774
45. R.J. Hogg, and R.J. Wyatt A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy Biomedical Central Nephrology 5 2004 3
46. A.C. Allen, F.R. Willis, and T.J. Beattie Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis Nephrol Dial Transplant 13 1998 930 934
47. Y. Hiki, H. Odani, and M. Takahashi Mass spectrometry proves under O-glycosylation of glomerular IgA1 in IgA nephropathy Kidney Int 59 2001 1077 1085
48. M. Tomana, J. Novak, and B.A. Julian Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan molecules J Clin Invest 104 1999 73 81
49. B.A. Julian, P.A. Quiggins, and J.S. Thompson Familial IgA nephropathy. Evidence of an inherited mechanism of disease N Engl J Med 312 1985 202 208
50. R.J. Wyatt, M.L. Rivas, and B.A. Julian Regionalization in hereditary IgA nephropathy Am J Hum Genet 41 1987 36 50
51. F. Scolari, A. Amoroso, and S. Savoldi Familial clustering of IgA nephropathy: further evidence in an Italian population Am J Kidney Dis 33 1999 857 865
52. M. Levy Multiplex families in IgA nephropathy Contrib Nephrol 104 1993 46 53
53. A.G. Gharavi, Y. Yan, and F. Scolari IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23 Nat Genet 26 2000 354 357
54. B.Y. Choy, T.M. Chan, and S.K. Lo Renal transplantation in patients with primary immunoglobulin A nephropathy Nephrol Dial Transplant 18 2003 2399 2404
55. R. Counahan, M.H. Winterborn, and R.H. White Prognosis of Henoch-Schönlein nephritis in children BMJ 2 1977 11 14
56. R. Coppo, G. Mazzucco, and L. Cagnoli Long-term prognosis of Henoch Schönlein nephritis in adults and children Nephrol Dial Transplant 12 1997 2277 2283
57. K. Scharer, R. Krmar, and U. Querfeld Clinical outcome of Schönlein-Henoch purpura nephritis in children Pediatr Nephrol 13 1999 816 823
58. M. Levy, M. Broyer, and A. Arsan Anaphylactoid purpura nephritis in childhood: natural history and immunopathology Adv Nephrol 6 1976 183 228
59. S.R. Meadow, and D.G. Scott Berger disease: Henoch-Schönlein syndrome without the rash J Pediatr 106 1985 27 31
60. F.B. Waldo Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12 1988 373 377
61. T. Watanabe, T. Takada, and I. Kihara Three cases of Henoch- Schönlein purpura preceded by IgA nephropathy Pediatr Nephrol 9 1995 674
62. C.D. West, A.J. McAdams, and J.M. McConville Hypocomplementemic and normocomplementemic persistent nephritis: clinical and pathological characteristics J Pediatr 67 1965 1089 1112
63. C.D. West Idiopathic membranoproliferative glomerulonephritis in childhood Pediatr Nephrol 6 1992 96 103
64. J.S. Cameron, D.R. Turner, and J. Heaton Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis Am J Med 74 1983 175 192
65. R. Habib, C. Kleinknecht, and M.C. Gubler Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases Clin Nephrol 1 1973 194 214
66. R.J. Wyatt, A.J. McAdams, and J. Forristal Glomerular deposition of complement-control proteins in acute and chronic glomerulonephritis Kidney Int 16 1979 505 512
67. R.E. Spitzer, E.H. Vallota, and J. Forristal Serum C'3 lytic system in patients with glomerulonephritis Science 164 1969 436 437
68. D.G. Williams C3 nephritic factor and mesangiocapillary glomerulonephritis Pediatr Nephrol 11 1997 96 98
69. A. Misra, A. Peethambaram, and A. Garg Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature Medicine (Baltimore) 83 2004 18 34
70. P. Galle, and P. Mahieu Electron dense alteration of kidney basement membranes. A renal lesion specific of a systemic disease Am J Med 58 1975 749 764
71. C.W. Clardy, J. Forristal, and C.F. Strife A properdin-dependent nephritic factor slowly activating C3, C5 and C9 in membranoproliferative glomerulonephritis types I and III Clin Immunol Immunopathol 50 1989 333 347
72. J.J. Neary, P.J. Conlon, and D. Croke Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1 J Am Soc Nephrol 13 2002 2052 2057
73. S. Ozdamar, S. Gucer, and K. Tinaztepe Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children Pediatr Nephrol 18 2003 23 28
74. P.T. McEnery, A.J. McAdams, and C.D. West The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis Medicine (Baltimore) 64 1985 401 424
75. P. Tarshish, J. Bernstein, and J.N. Tobin Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone-a report of the International Study of Kidney Disease in Children Pediatr Nephrol 6 1992 123 130
76. A. Levin Management of membranoproliferative glomerulonephritis: evidence-based recommendations Kidney Int Suppl 70 1999 S41 S46
77. J.J. Curtis, R.J. Wyatt, and D. Bhathena Renal transplantation for patients with type I and type II membranoproliferative glomerulonephritis: serial complement and nephritic factor measurements and the problem of recurrence of disease Am J Med 66 1979 216 225
78. T. Shimizu, K. Tanabe, and T. Oshima Recurrence of membranoproliferative glomerulonephritis in renal allografts Transplant Proc 30 1998 3910 3913
79. J.C. Jennette, and C.G. Hipp C1q nephropathy: a distinct pathologic entity usually causing nephritic syndrome Am J Kidney Dis 6 1985 103 110
80. K.K. Lau, L.W. Gaber, and R.J. Wyatt Pediatric C1q nephropathy: clinical presentation and outcome J Am Soc Nephrol 15 2004 A555 A556
81. R.J. Hogg for the Southwest Pediatric Nephrology Study Group Comparision of idiopathic and systemic lupus erythematosus-associated membranous glomerulopathy in children Am J Kidney Dis 7 1986 115 124
82. C.E. Kashtan Alport syndromes: phenotypic heterogeneity of progressive hereditary nephritis Pediatr Nephrol 14 2000 502 512
83. B.G. Hudson, S.T. Reeders, and K. Tryggvason Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis J Biol Chem 268 1993 26033 26036
84. I. Longo, P. Porcedda, and F. Mari COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome Kidney Int 61 2002 1947 1956
85. L. Callis, A. Vila, and M. Carrera Long-term effects of cyclosporine A in Alport's syndrome Kidney Int 55 1999 1051 1056
86. W. Proesmans, H. Knockaert, and D. Trouet Enalapril in paediatric patients with Alport syndrome: 2 years' experience Eur J Pediatr 159 2000 430 433
87. R.C. McCoy, H.K. Johnson, and W.J. Stone Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis Kidney Int 21 1982 642 652
88. D.C. Kluth, and A.J. Rees Anti-glomerular basement membrane disease J Am Soc Nephrol 10 1999 2446 2453
89. R. Kalluri, M.J. Sun, and B.G. Hudson The Goodpasture autoantigen: structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen J Biol Chem 271 1996 9062 9068
90. J.B. Levy, A.N. Turner, and A.J. Rees Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression Ann Intern Med 134 2001 1033 1042
91. D.J. Davies, J.E. Moran, and J.F. Niall Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus etiology? BMJ 285 1982 606 607
92. J.C. Jennette, R.J. Falk, and K. Andrassy Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 1994 187 192
93. M. Hattori, H. Kurayama, Y. Koitabashi for the Japanese Society for Pediatric Nephrology Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children J Am Soc Nephrol 12 2001 1493 1500
94. R.P. Valentini, W.E. Smoyer, and A.B. Sedman Outcome of antineutrophil cytoplasmic autoantibodies-positive glomerulonephritis and vasculitis in children: a single-center experience J Pediatr 132 1998 325 328
95. L.A. Baldree, L.W. Gaber, and C.P. McKay Anti-neutrophil cytoplasmic autoantibodies in a child with pauci-immune necrotizing and crescentic glomerulonephritis Pediatr Nephrol 5 1991 296 299
96. J.J. Weening, V.D. D'Agati, and M.M. Schwartz The classification of glomerulonephritis in systemic lupus erythematosus revisited J Am Soc Nephrol 15 2004 241 250
97. R.G. Barr, S. Seliger, and G.B. Appel Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity Nephrol Dial Transplant 18 2003 2039 2046
98. R. Bogdanovic, V. Nikolic, and S. Pasic Lupus nephritis in childhood: a review of 53 patients followed at a single center Pediatr Nephrol 19 2004 36 44
99. M.A. Dooley, S. Hogan, and C. Jennette Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network Kidney Int 51 1997 1188 1195
100. H.A. Austin III, D.T. Boumpas, and E.M. Vaughan Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data Kidney Int 45 1994 544 550
101. T.M. Chan, F.K. Li, and C.S. Tang Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 2000 1156 1162
102. G. Contreras, V. Pardo, and B. Leclercq Sequential therapies for proliferative lupus nephritis N Engl J Med 350 2004 971 980
103. M.A. Dooley, F.G. Cosio, and P.H. Nachman Mycophenolate mofetil therapy in lupus nephritis: clinical observations J Am Soc Nephrol 10 1999 833 839